1Bernstein, CN, Wajda, A, Svenson, LW, et al. (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101, 1559–1568.
2MacFarlane, AJ & Stover, PJ (2007) Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers. Nutr Rev 65, S157–S166.
3Shanahan, F & Bernstein, CN (2009) The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 25, 301–305.
4Bernstein, CN, Kraut, A, Blanchard, JF, et al. (2001) The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol 96, 2117–2125.
5Kappelman, MD, Rifas-Shiman, SL, Porter, CQ, et al. (2008) Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 135, 1907–1913.
6Itzkowitz, SH & Yio, X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287, G7–17.
7Eaden, JA, Abrams, KR & Mayberry, JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48, 526–535.
8Ekbom, A, Helmick, C, Zack, M, et al. (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323, 1228–1233.
9Rutter, M, Saunders, B, Wilkinson, K, et al. (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126, 451–459.
10Fox, JT & Stover, PJ (2008) Folate-mediated one-carbon metabolism. Vitam Horm 79, 1–44.
11Jiang, Y, Zhao, J, Jiang, T, et al. (2010) Genetic polymorphism of methylenetetrahydrofolate reductase G1793A, hyperhomocysteinemia, and folate deficiency correlate with ulcerative colitis in central China. J Gastroenterol Hepatol 25, 1157–1161.
12Chowers, Y, Sela, BA, Holland, R, et al. (2000) Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol 95, 3498–3502.
13Lashner, BA (1993) Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 119, 549–554.
14Lashner, BA, Provencher, KS, Seidner, DL, et al. (1997) The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112, 29–32.
15Biasco, G, Zannoni, U, Paganelli, GM, et al. (1997) Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev 6, 469–471.
16Mahmud, N, Molloy, A, McPartlin, J, et al. (1999) Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45, 389–394.
17Chen, M, Peyrin-Biroulet, L, Xia, B, et al. (2008) Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. BMC Med Genet 9, 78.
18Zintzaras, E (2010) Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies. Biomarkers 15, 69–79.
19Oussalah, A, Gueant, JL & Peyrin-Biroulet, L (2011) Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 34, 1173–1184.
20Halsted, CH, Gandhi, G & Tamura, T (1981) Sulfasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med 305, 1513–1517.
21Danese, S, Sgambato, A, Papa, A, et al. (2005) Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 100, 886–895.
22Phelip, JM, Ducros, V, Faucheron, JL, et al. (2008) Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis 14, 242–248.
23Papa, A, De Stefano, V, Danese, S, et al. (2001) Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol 96, 2677–2682.
24Drzewoski, J, Gasiorowska, A, Malecka-Panas, E, et al. (2006) Plasma total homocysteine in the active stage of ulcerative colitis. J Gastroenterol Hepatol 21, 739–743.
25Poddar, R, Sivasubramanian, N, DiBello, PM, et al. (2001) Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103, 2717–2723.
26Robert, K, Nehme, J, Bourdon, E, et al. (2005) Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 128, 1405–1415.
27Peyrin-Biroulet, L, Rodriguez-Gueant, RM, Chamaillard, M, et al. (2007) Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol 102, 1108–1115.
28Neufert, C, Becker, C & Neurath, MF (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2, 1998–2004.
29Boivin, GP, Washington, K, Yang, K, et al. (2003) Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124, 762–777.
30Whiteley, LO, Hudson, L Jr & Pretlow, TP (1996) Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol Pathol 24, 681–689.
31Riddell, RH, Goldman, H, Ransohoff, DF, et al. (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14, 931–968.
32Herbig, K, Chiang, EP, Lee, LR, et al. (2002) Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J Biol Chem 277, 38381–38389.
33Abnous, K, Brooks, SP, Kwan, J, et al. (2009) Diets enriched in oat bran or wheat bran temporally and differentially alter the composition of the fecal community of rats. J Nutr 139, 2024–2031.
34Brooks, SP, Kheradpir, E, McAllister, M, et al. (2009) In-feed administered sub-therapeutic chlortetracycline alters community composition and structure but not the abundance of community resistance determinants in the fecal flora of the rat. Anaerobe 15, 145–154.
35Schloss, PD, Westcott, SL, Ryabin, T, et al. (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75, 7537–7541.
36Tamura, K, Dudley, J, Nei, M, et al. (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24, 1596–1599.
37Schloss, PD, Larget, BR & Handelsman, J (2004) Integration of microbial ecology and statistics: a test to compare gene libraries. Appl Environ Microbiol 70, 5485–5492.
38Jones, RT & Martin, AP (2006) Testing for differentiation of microbial communities using phylogenetic methods: accounting for uncertainty of phylogenetic inference and character state mapping. Microb Ecol 52, 408–417.
39Lozupone, C, Hamady, M & Knight, R (2006) UniFrac – an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 7, 371.
40Schloss, PD (2008) Evaluating different approaches that test whether microbial communities have the same structure. ISME J 2, 265–275.
41Lozupone, CA, Hamady, M, Kelley, ST, et al. (2007) Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol 73, 1576–1585.
42Beals, EW (1984) Bray–Curtis ordination: an effective strategy for analysis of multivariate ecological data. Adv Ecol Res 14, 1–55.
43Stackebrandt, E & Goebel, BM (1994) Taxonomic note: a place for DNA–DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology. Int J Syst Bacteriol 44, 846–849.
44Chapkin, RS, Kamen, BA, Callaway, ES, et al. (2009) Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer. J Nutr Biochem 20, 649–655.
45Pretlow, TP & Pretlow, TG (2005) Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 1756, 83–96.
46Cole, BF, Baron, JA, Sandler, RS, et al. (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297, 2351–2359.
47Wu, K, Platz, EA, Willett, WC, et al. (2009) A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 90, 1623–1631.
48Figueiredo, JC, Mott, LA, Giovannucci, E, et al. (2011) Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer 129, 192–203.
49Carrier, J, Medline, A, Sohn, KJ, et al. (2003) Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice. Cancer Epidemiol Biomarkers Prev 12, 1262–1267.
50Mondot, S, Kang, S, Furet, JP, et al. (2011) Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis 17, 185–192.
51Willing, BP, Dicksved, J, Halfvarson, J, et al. (2010) A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844–1854.
52Lyra, A, Rinttila, T, Nikkila, J, et al. (2009) Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 15, 5936–5945.
53Lupp, C, Robertson, ML, Wickham, ME, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119–129.
54Kassinen, A, Krogius-Kurikka, L, Makivuokko, H, et al. (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24–33.
55Nagalingam, NA, Kao, JY & Young, VB (2011) Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 17, 917–926.